This inventor holds 1 USPTO granted patent. Top assignee: Universidad De Granada. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations in Tumor Treatment by Javier Florido Ruiz
Introduction
Javier Florido Ruiz is an innovative inventor based in Granada, Spain. He has made significant contributions to the field of pharmaceutical compositions, particularly in the treatment of tumors. His work focuses on the use of melatonin, a hormone known for its role in regulating sleep, as a potential therapeutic agent against cancer.
Latest Patents
Javier Florido Ruiz holds a patent for the "Use of melatonin for the treatment of tumors." This invention relates to the preparation of a pharmaceutical composition suitable for intratumoral administration. The composition comprises high concentrations of melatonin, melatonin derivatives, or metabolites. The unique aspect of this invention is that melatonin exerts an oxidizing effect, which increases the production of free radicals and activates cell death in tumor cells. This innovative approach could pave the way for new treatment options in oncology.
Career Highlights
Javier is affiliated with the Universidad de Granada, where he conducts research and develops his innovative ideas. His academic background and research experience have equipped him with the knowledge necessary to explore the therapeutic potential of melatonin in cancer treatment. His dedication to advancing medical science is evident in his work and contributions to the field.
Collaborations
Javier has collaborated with notable colleagues, including Germaine Escames Rosa and Darío Acuña Castroviejo. These collaborations have likely enriched his research and contributed to the development of his innovative patent.
Conclusion
Javier Florido Ruiz is a pioneering inventor whose work on melatonin for tumor treatment represents a significant advancement in cancer therapy. His innovative approach could lead to new and effective treatment options for patients battling tumors.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
